test

Neb Obradovic

@Cormorant Asset Management, Lp

Latest period2024 - Q3ReportedManaged Assets$1.886BTotal holdings45
Assets growth rate8.94%Assets growth rate (2-Q avg)-7.56%Continuous growth in asset value1 quarters

Portfolio positions

This chart displays the top 10 holdings in Cormorant Asset Management, Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 45 positions.

Assets under management

The assets under management (AUM) of Cormorant Asset Management, Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 1 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.886B in assets, with a quarterly growth rate of 8.94% and a 2-quarter average growth rate of -7.56%. The portfolio is managed by Neb Obradovic, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
RNAAvidity Biosciences Inc
Recent Activity
Increased 147.06%
2.56%
$48.226M
1.05M shares@ $45.93 avg price
JANXJanux Therapeutics Inc
Recent Activity
2.53%
$47.701M
1.05M shares@ $45.43 avg price
BBIOBridgebio Pharma Inc
Recent Activity
2.51%
$47.314M
1.858M shares@ $25.46 avg price
NAMSNewamsterdam Pharma Company
Recent Activity
Increased 7.4%
2.18%
$41.002M
2.47M shares@ $16.6 avg price
CNTACentessa Pharmaceuticals Plc
Recent Activity
Increased 58.95%
2.18%
$40.96M
2.562M shares@ $15.99 avg price
MRUSMerus N V
Recent Activity
Decreased -11.9%
1.97%
$36.97M
740,000 shares@ $49.96 avg price
CGONCg Oncology Inc
Recent Activity
1.96%
$36.787M
975,000 shares@ $37.73 avg price
INSMInsmed Inc
Recent Activity
Decreased -25.92%
1.94%
$36.5M
500,000 shares@ $73.0 avg price
BMEABiomea Fusion Inc
Recent Activity
1.92%
$36.066M
3.571M shares@ $10.1 avg price
AXSMAxsome Therapeutics Inc
Recent Activity
1.91%
$35.948M
400,000 shares@ $89.87 avg price